Articles – Page 2 – Covid-19 Notes

BC > Adverse Events Following Immunization > death

Adverse Events Following Immunization

Death is reportable as an adverse event when it occurs within 30 days of vaccination and no other clear cause of death has been established. Death may also be recorded as the outcome
of a specific reportable event. Fifteen serious AEFI reports were received for individuals who died within 30 days of receiving a COVID-19 vaccine.

 For five of the deaths, vaccination was not considered to be a contributing factor by the
health care provider or coroner who attended and investigated the death and
considered the individuals’ medical history.
 One death occurred in a long term care resident following deterioration with reduction
in oral intake, without a clear underlying cause of death identified.
 In six individuals, death was the outcome of cardiac arrest. Five of these were elderly
individuals, many with multiple underlying medical conditions, while the other had
cardiac risk factors and was hospitalized for a myocardial infarction.
 Two deaths occurred in elderly individuals following a stroke and hospital admission.
Both had previous history of stroke along with other medical conditions.
 One death occurred in an individual with metastatic cancer who had been hospitalized
for complications of thrombocytopenia and hemolytic anemia.

PDF (page 7)

http://www.bccdc.ca/Health-Info-Site/Documents/COVID-19_vaccine/AEFI_reports/COVID19_AEFI_Weekly_Report_2021-09-16.pdf

Biden Covid team sees vaccine efficacy waning in unpublished data from Israel

The Israel data, which is set to be made public as soon as this week, shows that the Pfizer vaccine’s ability to prevent severe disease and hospitalization is waning over time — as is the shot’s protection against mild and moderate disease, the two sources said.

Biden Covid team sees vaccine efficacy waning in unpublished data from Israel

The data, which is set to be made public as soon as this week, shows that the Pfizer vaccine’s ability to prevent severe disease and hospitalization is waning over time.

Why is there no debate about ‘leaky’ vaccines?

There have been concerns in the medical world about ‘leaky’ vaccines, like the Covid ones, for years. So why are experts who come forward to raise the alarm either being silenced or suffering character assassination by the media?

Why is there no debate about ‘leaky’ vaccines?

There have been concerns in the medical world about ‘leaky’ vaccines, like the Covid ones, for years. So why are experts who are coming forward to raise concerns either being silenced or suffering character assassination by the media?

Latest Data on COVID-19 Vaccinations by Race/Ethnicity

“As of September 8, 2021, CDC reported that race/ethnicity was known for 59% of people who had received at least one dose of the vaccine. Among this group, nearly two thirds were White (60%), 10% were Black, 17% were Hispanic, 6% were Asian, 1% were American Indian or Alaska Native, and <1% were Native Hawaiian or Other Pacific Islander, while 5% reported multiple or other race.”

Latest Data on COVID-19 Vaccinations by Race/Ethnicity

KFF is collecting and analyzing data on COVID-19 vaccinations by race/ethnicity to gain increased insight who is receiving the vaccine and whether some groups are facing disparities in vaccination.

Our Most Reliable Pandemic Number Is Losing Meaning

In other words, the study suggests that roughly half of all the hospitalized patients showing up on COVID-data dashboards in 2021 may have been admitted for another reason entirely, or had only a mild presentation of disease.

Our Most Reliable Pandemic Number Is Losing Meaning

A new study suggests that almost half of those hospitalized with COVID-19 have mild or asymptomatic cases.

Pfizer > waning effectiveness not because of Delta

Evidence gathered in studies conducted both in Israel and in the United States by Kaiser Permanente Southern California and the CDC indicate that the observed decrease of vaccine effectiveness against COVID-19 infections is primarily due to waning of vaccine immune responses over time rather than a result of the Delta variant escaping vaccine protection.

PDF (page 46)

https://www.fda.gov/media/152161/download

Ivermectin, ‘Wonder drug’ from Japan: the human use perspective

Discovered in the late-1970s, the pioneering drug ivermectin, a dihydro derivative of avermectin—originating solely from a single microorganism isolated at the Kitasato Intitute, Tokyo, Japan from Japanese soil—has had an immeasurably ...

UK > JCVI issues updated advice on COVID-19 vaccination of children aged 12 to 15

The assessment by the Joint Committee on Vaccination and Immunisation (JCVI) is that the health benefits from vaccination are marginally greater than the potential known harms. However, the margin of benefit is considered too small to support universal vaccination of healthy 12 to 15 year olds at this time.

JCVI issues updated advice on COVID-19 vaccination of children aged 12 to 15

The JCVI has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased risk from severe COVID-19.

Study Reveals Declining COVID-19 Vaccine Efficacy Against Infection

Today’s report tracked the cohort through August 14—incorporating over four more months of data that include a time period in which the Delta variant swept the country—and found that overall, vaccine effectiveness dipped to 66 percent in the weeks when the variant accounted for at least 50 percent of SARS-CoV-2 viruses sequenced. What the study can’t answer is why effectiveness dipped in the weeks dominated by Delta.

Study Reveals Declining COVID-19 Vaccine Efficacy Against Infection

The vaccines remain protective against serious disease and death.

FDA > Emergency Use Authorization

FDA may authorize unapproved medical products or unapproved uses of approved medical products to be used in an emergency to diagnose, treat, or prevent serious or life-threatening diseases or conditions caused by CBRN threat agents when certain criteria are met, including there are no adequate, approved, and available alternatives.

Emergency Use Authorization

Emergency Use Authorization (EUA) information, and list of all current EUAs